r ImaRx Therapeutics    Clinical Trials
 

Clinical Trials

TUCSON (Transcranial Ultrasound in Clincal SONolysis)
Phase I / II study evaluating our proprietary MRX-801 microbubbles, ultrasound and tPA for the treatment of acute ischemic stroke.

Status: Study concluded. Results to be presented at 2009 International Stroke Conference.


Terms of Use Copyright © 2000 - 2009 ImaRx Therapeutics, Inc. All rights reserved.